PB127 for injectable suspension

DRUG6 trials

Sponsors

Point Biomedical

Conditions

Coronary Artery DiseaseHealthy

Phase 2

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

TerminatedNCT00487903

Point BiomedicalCoronary Artery Disease, Healthy

Start: 2007-09-30End: 2008-03-31Target: 40Updated: 2008-07-03

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

CompletedNCT00584818

Point BiomedicalCoronary Artery Disease, Healthy

Start: 2006-11-30End: 2008-03-31Updated: 2008-04-25

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

CompletedNCT00594698

Point BiomedicalCoronary Artery Disease

Start: 2002-02-28End: 2003-09-30Updated: 2008-07-03

Phase 3

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

TerminatedNCT00584896

Point BiomedicalCoronary Artery Disease

Start: 2007-10-31End: 2008-07-31Target: 1000Updated: 2008-07-03

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

CompletedNCT00595244

Point BiomedicalCoronary Artery Disease

Start: 2002-07-31End: 2003-10-31Updated: 2008-07-03

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

CompletedNCT00595673

Point BiomedicalCoronary Artery Disease

Start: 2002-07-31End: 2003-10-31Updated: 2008-07-03